Serving 500+ biopharmaceutical companies globally:

Deloitte
Fuji
Johnson and Johnson
Queensland Health
US Department of Justice
McKinsey
Boehringer Ingelheim
Chubb
Colorcon
Citi

Pharmaceutical companies with the most 'New Patient Population' drugs

This chart shows the companies which have received the most New Patient Population exclusivities in the past five years.

New Patient Populations are one of the categories for which the FDA grants three years of exclusivity for 'New Clinical Investigations.'

Alternate categories worth of three years of protection include identifying a New Combination, New Product, or New Strength.

The companies with the most New Patient Populations drugs are:

Back to Pharmaceutical Industry Infographics

For more information try a trial or see the database preview and plans and pricing

botpot